欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/3063/001
药品名称Vizilaticom
活性成分
    • Latanoprost 50.0 µg/ml
    • Timolol 5.0 mg/ml
剂型Eye drops, solution
上市许可持有人Bausch Health Ireland Limited 3013 Lake Drive Citywest Business Campus Dublin 24 Ireland
参考成员国 - 产品名称Denmark (DK)
Vizilatan Duo
互认成员国 - 产品名称
    • Germany (DE)
      Vizilatan Duo
    • Belgium (BE)
      Vizilaticom 50 microgrammes/ml + 5 mg/ml, collyre en solution
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      Vizilatan Duo 0,05 mg/ml + 5 mg/ml Augentropfen, Lösung
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Vizilatan Duo
    • Hungary (HU)
    • Czechia (CZ)
      VIZALATAN DUO
许可日期2020/03/04
最近更新日期2024/10/22
药物ATC编码
    • S01ED51 timolol, combinations
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase